Literature DB >> 2124960

HLA class II glycoprotein expression by monocytes from HIV-infected individuals: differences in response to interferon-gamma.

B S Zwilling1, R Darrow, M Mcpeek, H Laufman, D Pearl.   

Abstract

The expression of HLA class II glycoproteins by monocytes from HIV-infected individuals was evaluated. We found no differences in HLA-DR, HLA-DQ, or HLA-DP expression by freshly isolated monocytes from patients with clinical AIDS, HIV-infected patients without AIDS or from uninfected individuals. However, monocytes from HIV-infected individuals without AIDS responded better to stimulation with recombinant human interferon-gamma (IFN-gamma) than did monocytes from patients with clinical AIDS or from uninfected individuals. The response to IFN-gamma stimulation by monocytes from patients with clinical AIDS was different. Thus, the largest increases in the percentage of cells expressing HLA-DR was associated with the smallest changes in the fluorescence intensity of the population that is observed following stimulation of monocytes from other patient populations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124960      PMCID: PMC1535493          DOI: 10.1111/j.1365-2249.1990.tb05489.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

Review 1.  Antigen-presenting function of the macrophage.

Authors:  E R Unanue
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

2.  All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.

Authors:  T A Gonwa; J P Frost; R W Karr
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

Review 3.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules.

Authors:  L A Matis; L H Glimcher; W E Paul; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  The use of the avidin-biotin complex as a tool in molecular biology.

Authors:  E A Bayer; M Wilchek
Journal:  Methods Biochem Anal       Date:  1980

7.  Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells.

Authors:  A J Petit; F G Terpstra; F Miedema
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

8.  Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.

Authors:  W Heagy; V E Kelley; T B Strom; K Mayer; H M Shapiro; R Mandel; R Finberg
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Differential expression of Ia molecules by human monocytes.

Authors:  T A Gonwa; J D Stobo
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

10.  Monocyte phenotype and function in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.

Authors:  J G Haas; G Riethmüller; H W Ziegler-Heitbrock
Journal:  Scand J Immunol       Date:  1987-10       Impact factor: 3.487

View more
  2 in total

1.  Preserved MHC class II antigen processing in monocytes from HIV-infected individuals.

Authors:  Laila Woc-Colburn; Lavinia Smultea; Lakshmi Ramachandra; David H Canaday
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

2.  The expression of HLA-DR by monocytes from black and from white donors: different requirements for protein synthesis.

Authors:  M McPeek; J Salkowitz; H Laufman; D Pearl; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.